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Summary. — The expanding role of particle-based radiation treatment of cancer
(hadrontherapy) requires a thorough understanding of its possible late effects at the
cellular and tissue levels. The biological effectiveness of a 12C ion beam in the induc-
tion of two biological endpoints, neoplastic transformation and premature cellular
senescence was studied in human cells in vitro and compared to that exhibited by low
linear energy transfer (LET) radiation. Cells were exposed to the therapeutic 12C
ion beam used at GSI at various positions of the beam ionisation path, correspond-
ing to the low-LET entrance channel (plateau), the high-LET Spread-Out Bragg
Peak (SOBP) or at 3.8 cm past the SOBP. In the framework of the INFN-funded
project ETIOPE, this paper reports preliminary results on survival and neoplastic
transformation after a physical dose of 0.75Gy, and on the onset of cellular senes-
cence after 0.5 or 2Gy of plateau- and SOBP-irradiated cells. A three-dimensional
approach to investigate the effects 12C ion beams on the expression of cell adhesion
molecules is also examined.
PACS 87.53.-j – Effects of ionizing radiation on biological systems.
PACS 87.53.Jw – Therapeutic applications, including brachytherapy.
PACS 87.19.xj – Cancer.
PACS 87.55.dh – Tissue response.
1. – Introduction
The use of protons and heavier charged particles such as 12C ion beams in the treat-
ment of cancer, commonly referred to as hadrontherapy [1], may entail significant ther-
apeutic gains compared to conventional radiotherapy (photons) because of the physical
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properties of dose deposition within the irradiated tissue as described by Bragg’s curve,
and the ion beams’ radiobiological properties [2]. The former allows a greater sparing of
the healthy tissue as the dose deposited rises steeply as the particles’ range nears its end
reaching a maximum (Bragg peak), which can be modulated in order to encompass the
tumour linear dimensions. Furthermore, a reasonably homogenous biologically effective
dose can be achieved along such a Spread-Out Bragg Peak (SOBP), which, in the case of
12C ions, elicits a higher Relative Biological Effectiveness (RBE) compared to photons as
well as protons in the induction of curative endpoints such as tumour cell inactivation [3].
Carbon ion-based hadrontherapy therefore represents a useful approach to eradicating
tumours that are otherwise resilient to photon therapy. However, the existing paucity of
data on the RBE for adverse long-term effects due to ion beam exposure, such as cancer
or tissue degeneration [4], represents a source of uncertainty in light of a wider use of
hadrontherapy. Knowledge of late effects of ion beam irradiation is needed for both the
Linear Energy Transfer (LET) values prior to the SOBP as well as those immediately
beyond it. The healthy tissue exposed in the entrance beam channel will inevitably re-
ceive a dose, which albeit reduced compared to that due to a photon beam and 2-3 fold
less than that released in the SOBP, is likely to be biologically relevant because of the
great effectiveness of the ions at causing serious lesions (damage clusters) to the cell’s
DNA. Likewise, despite the rapid decrease in the energy released after the SOBP, the
fragmentation of the incident beam with the nuclei of the biological targets may result in
the normal cells of the tissue seated beyond the end of the beam penetration range being
hit by slowed-down fragments [5], hence having higher linear energy transfer (LET) than
the pristine beam and of unknown biological relevance.
Cancer is a well-known somatic late effect of ionising radiation. Photon radiotherapy
has been shown to be associated with a significant enhancement in the risk of secondary
tumour induction in long-term survivors [6]. With heavy ions, no experience is available
to estimate risk of second malignancies induction, an aspect of great concern in the case of
the treatment of younger patients because of their longer life span. The development of in
vitro oncogenic transformation assay systems has made it possible to assess, at the cellular
level, the carcinogenic potential of a variety of physical and chemical agents. These
systems are particularly suitable for comparing different agents or treatment modalities
risk [7]. Additional advantages are that cell survival can be determined in parallel to
transformation, the cells can be irradiated in track-segment conditions and they can be
used to investigate definite positions within a certain radiation field. The human hybrid
(Hela X skin fibroblast) cell line, developed by Stanbridge et al. [8] and Redpath et
al. [9] and designated CGL1 has been used to compare carbon ion beams to conventional
photon irradiation. In a first phase monoenergetic 12C ion beams of energies between
270 and 11.4MeV/n (LET values between 13.8 and 172 keV/μm) were investigated [10];
more recently, the irradiation of an extended tumour volume has been simulated and
survival, neoplastic transformation and micronuclei induction have been measured in
different positions of the ionisation profile along the beam penetration direction [11,12].
As opposed to the extensively studied cancer-related long-term effects, non-cancer
degenerative diseases induced by ionising radiation have been only recently attracting
attention as a source of health concern. It is known that high-energy heavy ions are par-
ticularly efficient at causing degenerative alterations, showing a high RBE for cataract
and neurodegenerative diseases [13], hence possessing a capacity of accelerating the phys-
iological ageing of the exposed tissues. More recently, analysis of data from Hiroshima
and Nagasaki survivors has confirmed a significant increase in the incidence of cardiovas-
cular mortality [14]. Although these data refer to doses higher than those hadrontherapy
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patients will incur, it is nevertheless necessary to reduce the uncertainty surrounding the
RBE of charged particles for such late effects thereby optimising treatment plans.
Ionising radiation has been reported to promote a state of apparent cell-cycle arrest
in both normal and tumour cell lines closely resembling the senescent phenotype [15-17].
The latter is the physiological fate incurred by all somatic primary cell lines when cultured
in vitro because of the exhaustion of their proliferative potential but there is convincing
evidence that such a phenotype occurs also in vivo and is related to the accumulation of
cells containing shortened telomere sequences [18]. However, many stimuli, at sub-lethal
doses, can ectopically provoke the senescence pathway [19]. Although DNA damage is
thought to be the main effector of the senescent-like fate [15], the underlying mecha-
nisms of stress-induced premature senescence (SIPS) are not understood [20,21]. It may
be triggered by oncogene(s) [22]: premature entry into senescence would thus represent
a stress-induced avoidance of transformation; it could be associated with telomere short-
ening [23], in which case, since reduction of telomere length below a critical threshold
is thought to result in telomere-telomere fusion, widespread genome instability and in-
creased tumourigenic risk would ensue. Moreover, the role of SIPS in radiotherapy needs
to be ascertained [21].
Since the ubiquitous endothelial tissue represents one of the chief targets of tissue-
related effects of irradiation as demonstrated by the capillary-initiated radiopathogenesis
of several organs [24], the ectopic onset of senescence and its relationship with telom-
ere length was studied in human umbilical vein endothelial cells (HUVECs). HUVECs
have been widely used for investigating angiogenesis and tumourigenesis of the endothe-
lium [25]. They are known to show progressive telomere shortening with time in cul-
ture [26]. Previously, 12C ion-induced clonogenic cell death was determined in this sys-
tem [27]. The therapeutic beam was shown to be 2-fold and 3-fold more effective at
cell killing than X-rays in the plateau region and at the SOBP, respectively. In this
study, senescence was revealed by positivity for β-galactosidase activity according to the
biomarker assay established by Dimri et al. [28] while cytogenetic analysis of telomeres
was performed by Interphase Quantitative (IQ)- FISH, adapting a methodology origi-
nally developed by others [29,30]. By both assays, the effectiveness of 12C ions at causing
HUVECs to senesce prematurely was studied and compared to that exhibited following
X-ray irradiation.
Most of experimental data on the effects of ionising radiation have relied on conven-
tional in vitro cell culture techniques based on cell monolayers. The need of furthering
radiobiological studies to three-dimensional systems that better model the complex cell-
to-cell signalling and interplay deriving from the in vivo tissue architecture is widely
acknowledged, an example of which is provided by the spheroid system [31]. The set-up
of a spheroid-based approach to compare previous results on gamma-ray–induced modi-
fications of cell adhesion molecules of interest in endothelial tissue late effects with those
from 12C ion irradiation will be discussed.
2. – Experimental procedure
2.1. Neoplastic transformation. – CGL1 cells are not tumourigenic when injected in
nude mice whereas transformed cells form carcinomas. Expression of tumourigenicity
in these cells is associated with the expression of a cell surface protein, which has been
identified as an intestinal alkaline phosphatase IAP [32]. This protein is readily detected
by the alkaline phosphatase chromogenic substrate, Western Blue. Therefore, blue foci of
transformed cells are scored against the white background of the normal cells. Details on
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cell culture, transformation assay protocol and irradiation procedure have been reported
previously [10, 11, 33]. Briefly, about 20 h before irradiation, exponentially growing cells
were seeded into standard tissue culture (T25) flasks. Immediately after irradiation,
cells were removed by trypsinization and then plated in T75 flasks at a cell concentration
such that the resulting number of viable cells was as close to 50 viable cells per cm2 as
possible. After 21 days of incubation, with the growth medium changed once a week,
the cultures were fixed and stained with Western Blue. For each experiment in parallel
with the transformation assay small aliquots of the cell suspensions were also plated in
T25 flasks for the evaluation of the surviving fraction allowing colonies to grow for about
12 days after irradiation.
2.2. Cellular senescence. – Early passage HUVECs were irradiated at the SIS fa-
cility in Darmstadt using a 270MeV/n carbon ion beam representing the plateau
(LET ≈ 13 keV/μm) region and at the centre of a 1 cm SOBP (LET ≈ 100 keV/μm)
at a depth of approximately 35mm as to examine the senescence-related late effects
in both the healthy tissue at the beam entrance channel and in the tumour-associated
endothelium. Two doses were chosen for each position, one of relatively sub-lethal mag-
nitude (0.5Gy) and the other known to reduce HUVEC survival by one log compared
to the former for either LET value [27], i.e. 2Gy. X-rays were used as a reference, doses
being chosen as to give approximately the same clonogenic survival as previously de-
termined [27]. At the first passage post-irradiation, irradiated flasks were sub-cultured
taking into account estimated clonogenic survival. Each sample was thus split, serially
cultivated and, at regular intervals, either harvested or replated. Harvested samples were
either processed for β-galactosidase assay as directed by manufacturer (Sigma-Aldrich,
USA) or for IQ-FISH. The latter was carried out by analysing interphase cells on slides
that were co-hybridised with a pantelomeric probe (Dako, Denmark) and a centromeric
probe (Olympus, Italy), specific for chromosome 12. The assumption is that the inten-
sity of the fluorescence emitted by telomere-conjugated probes is proportional to telomere
length [30]. The two probes emit in the red and green portion of the visible spectrum
respectively when examined at the fluorescence microscope. In-house fluorescence signal
analysis was used by opportunely adapting a classifier for automated metaphase search
(software by MetaSystems, Germany): single cells were localised and signals were ac-
quired by scanning ten planes around the mid-focal plane at 1.5μm steps. The ratio of
the red fluorescence intensity (telomeres) was divided by the green fluorescence inten-
sity (centromere) as to normalise the telomere fluorescence thereby making it possible to
provide a measure that is independent of slide-to-slide variations.
2.3. Spheroids. – The human tumour cell line MG-63 will be used to grow spheroid
aggregates. The levels of cell death induced by SOBP irradiation will be compared to
those already obtained after 5Gy of γ-rays. Cell death will be assessed by Hoechst 33258
staining. In the case of low LET irradiation, the expression of adhesion molecules was
analysed using the inhibitor zVAD-fmk.
3. – Results
3.1. Transformation induction. – CGL1 cells were irradiated at the medical exposure
set-up at SIS, GSI. An extended volume simulating a tumour in a depth between 6 and
10 cm was irradiated with physical isodoses of 0.75Gy. Survival and neoplastic trans-
formation have been determined in six different positions of the beam ionisation profile
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Fig. 1. – Survival (a) and neoplastic transformation (b) vs. depth along the ionisation path of
the 12C ion beam. The corresponding physical dose values are also reported (right axis).
from the entrance channel to the region behind the SOBP to evaluate the role of nuclear
fragments. Figures 1a and 1b show survival and neoplastic transformation frequency
at the various positions of the dose-depth curve. The corresponding physical dose val-
ues are also reported (right axis). Survival decreases with increasing depth reaching a
minimum in the simulated tumour volume. Correspondingly, neoplastic transformation
frequency increases with increasing depth reaching a maximum in same position. The
decrease/increase in survival/transformation with depth is expected on the basis of the
increase of dose and LET with increasing depth. These results are in line with those
obtained in previous experiments on monoenergetic 12C-ion beams with energy between
270 and 11.4MeV/n (LET values between 13.8 and 172 keV/μm) [10]. In fact, it was
found that the 270MeV/n 12C ions at the entrance channel show an oncogenic and killing
potential very similar to that of photons, whereas the lowest energy /highest LET shows
at low doses a RBE of about 7 and 12 for survival and transformation, respectively.
Behind the tumour volume, where the physical dose is low compared with the entrance
(a factor of about ten) and is due to nuclear fragments, survival is similar to the control
values, i.e. 1; on the other end, transformation frequencies are greater than those relative
to the controls and similar to the values at the entrance.
3.2. Radiation-induced premature senescence. – Data from β-galactosidase assay
clearly show that irradiation causes premature senescence (fig. 2). A greater proportion
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Fig. 2. – Fraction of senescent cells as a function of radiation quality and dose at various passages.
of cells expressing β-galactosidase activity was found amongst irradiated cells, exposed
to both 12C and X-ray, compared to the irradiated control from the same passage. The
dependence upon dose or radiation quality is rather complex but points to a greater
effectiveness of low dose vs. high dose in the earlier passages post-irradiation; at these
passages and for the low doses used, high LET seems also to be more effective than low
LET. At later times no clear dependence upon LET or dose was seen although descen-
dants from irradiated cultures continued to exhibit a higher incidence of senescence than
those from unirradiated controls. These data thus point to two temporally distinct waves
of cellular senescence, an early radiation-induced senescence that is both LET and dose
dependent, and a late senescence. These results are in qualitative agreement with data
from Fournier et al. [34] on fibroblasts irradiated with various radiation qualities and are
consistent with high doses of high LET radiation preferably inducing lethal effects while
sub-lethal damage being able to induce premature senescence.
As regards the ratio T/C as an indicator of telomere length, a decrease was seen
in ageing controls, thereby validating its use as a cytogenetic marker of senescence.
Preliminary results indicate that a correlation between telomere shortening and radiation-
induced premature senescence occurred for 12C ion irradiation at the plateau position
and for X-ray irradiation, although in the latter case an initial whereas no clear trend
was observed for SOBP irradiation (fig. 3).
3.3. Three-dimensional approach. – Previous studies with gamma-rays have shown
that radiation-induced cell death levels depend on the three-dimensional organization of
the irradiated cultures. When monolayers were irradiated, mitotic catastrophe was preva-
lent as mode of death, whereas apoptosis prevailed in the case of irradiated spheroids [35].
Protein analysis seems to corroborate the view that hypoxia may be involved in such pro-
cesses.
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Fig. 3. – Relationship between telomere length, as measured by telomere to centromere fluores-
cence intensity ratio (T/C), and cellular senescence as assayed by β-galactosidase expression.
4. – Conclusions
The INFN-funded project ETIOPE aims at studying the effectiveness in the induction
of neoplastic transformation and the onset of premature senescence in human cell lines
by a therapeutic 12C ion beam relative to photon irradiation.
Late-arising biologically relevant effects may be tumourigenic, i.e. leading to sec-
ondary cancers, possibly promoted by DNA lesions such as chromosome aberrations or
non-targeted damage in the form of genomic instability, and non-tumourigenic. The
latter can be brought forward by cell death or stress-induced cellular damage such as
premature senescence.
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As for neoplastic transformation, the results of the present study show that the onco-
genic potential of 12C ions in the SOBP is greater than at the beam entrance and that,
as opposed to cell killing, the oncogenic effect of the low-dose nuclear fragments behind
the tumour volume is not negligible. We are aware that these results pertain only to the
probability of neoplastic transformation of a single surviving cell and many other aspects
need to be taken into account in a therapy plan, nevertheless, as far as late effects are
concerned, they suggest the necessity of restricting high LET irradiation to the tumour
volume only and that the use of multiple opposing beam irradiation should be avoided
whenever possible.
Our data demonstrate that ionising radiation is capable of causing normal human
endothelial cells (HUVECs) to express markers of ageing earlier than do controls not
exposed to radiation. Such a response, which follows a complex dependence upon radi-
ation dose and quality, seems to occur in two phases: an early senescence appears to be
more effectively induced by 12C ions compared to X-rays as opposed to a delayed onset of
LET-independent senescence. For a given LET, low doses are also more effective at caus-
ing such early senescence. From a mechanistic point of view, our data seem to support
that radiation-induced premature senescence, at least in its early occurrence, is enacted
via telomere shortening for 12C ion irradiation in the plateau region, but do not suffice
to ascertain whether a similar mechanism is in place in the case of SOBP irradiation.
Altogether, these data seem to indicate that healthy tissues exposed to low doses of 12C
ions in the region of the dose-depth profile corresponding to the entrance beam channel,
of interest for late effects of hadrontherapy patients, may be susceptible to premature
senescence. Further experiments are warranted to confirm these results for the plateau
region, to clarify the dependence upon telomere shortening of such a response in the case
of SOBP and to examine the role of fragmentation in the onset of senescence.
The differential induction of cell death depending on the architecture of the irradiated
cells shown in the case of low LET irradiation suggests testing the spheroid system with
12C ions using isodoses in both the plateau and SOBP regions.
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